Dual-Pathway Inhibitor Targets Glomerular Disease Dual-Pathway Inhibitor Targets Glomerular Disease

A hypertension drug might benefit patients with primary focal segmental glomerulosclerosis, a rare kidney disease characterized by proteinuria, suggest early results from the DUET trial.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Nephrology News Source Type: news